Roundhill Glp-1 & Weight Loss ETF
NASDAQ:OZEM

  • LAST PRICE
    27.54
  • TODAY'S CHANGE (%)
    0.56 (2.08%)
  • Bid / Lots
    26.30/ 6
  • Ask / Lots
    27.50/ 1
  • Open / Previous Close
    27.13 / 26.98
  • Day Range
    27.13
    27.54
  • 52 Week Range
    24.51
    29.21
  • Volume
    26,673
  • Overall Morningstar Rating
    Not Ratedout of 268 funds

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Daily Premium/Discount

Bar Graph.See accessible table below
ETFs trading at a price higher than its Net Asset Value (NAV) is said to be trading at a premium, while those trading at price lower than its NAV is said to be at a discount. By showing the daily premium/discount percentage, we can see the trend in market sentiments, regarding the value of an ETF over time.

Holdings Diversification

Asset Class
Non-US Stock		51.6%
US Stock		48.3%
Cash		0.1%
Convertible		0
Non-US Bond		0
Other		0
Sectors
Healthcare99.9%
Basic Mat.0
Communication Services0
Consumer Cyclical0
Consumer Defensive0
Energy0
Financial Serv.s0
Industrials0
Real Estate0
Technology0
Utilities0
Geographic Region
United States		48.3%
Asia/Oceania		12.4%
Africa		0
Latin America		0
Canada		0
Europe		0
As of 2024-10-31

Top 10 Holdings

Company NamePositionAllocation
Allocation
1 Month Change
Market Value
NVO
Novo Nordisk AS ADR
Long
17.3%
0.00%
$8.3M
LLY
Eli Lilly and Co
Long
14.6%
0.00%
$7.0M
Zealand Pharma AS
Long
5.0%
0.00%
$2.4M
Roche Holding AG
Long
4.9%
0.00%
$2.4M
VKTX
Viking Therapeutics Inc
Long
4.5%
0.00%
$2.2M
Chugai Pharmaceutical Co Ltd
Long
4.4%
0.00%
$2.1M
AZN
AstraZeneca PLC ADR
Long
4.1%
0.00%
$1.9M
ALT
Altimmune Inc
Long
3.8%
0.00%
$1.8M
GPCR
Structure Therapeutics Inc ADR
Long
3.7%
0.00%
$1.8M
AMGN
Amgen Inc
Long
3.4%
0.00%
$1.6M
As of 2024-11-05

Reports

No reports available

Morningstar Ratings

Time HorizonStar Rating
Overall RatingNot Rated
3 Year RatingNot Rated
5 Year RatingNot Rated
10 Year RatingNot Rated
As of 2024-10-31

Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.

Style Box is calculated only using the long position holdings of the portfolio.

ETF Profile
Best Fit Index
N/A
Category
Health
Sponsor
Roundhill Financial Inc.
Inception
May 20, 2024
As of 2024-10-31

The investment seeks to provide capital appreciation. The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.

Holding Details
Total Net Assets$47.9M
Shares Out.1.8M
Net Asset Value (NAV)$27.53
Prem/Discount to NAV0.05%
P/E Ratio29.5
Dividend Yield0.00%
Dividend per Share---
Ex-Dividend Date---
Dividend Payment Date---
Beta---
Morningstar Investment StyleHealth
Equity Style
Large Cap Growth
Credit Quality / Duration
---
Fees & Expenses
Actual Management Fee0.59%
Actual Mgmt. Expense Ratio (MER)---